International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions (NEXT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01373502
Recruitment Status : Completed
First Posted : June 15, 2011
Last Update Posted : April 30, 2018
Information provided by (Responsible Party):
CID - Carbostent & Implantable Devices

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : October 2015